Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy.
Beyranvand Nejad E, Labrie C, Abdulrahman Z, van Elsas MJ, Rademaker E, Kleinovink JW, van der Sluis TC, van Duikeren S, Teunisse AFAS, Jochemsen AG, Oosting J, de Miranda NFCC, Van Hall T, Arens R, van der Burg SH.
Beyranvand Nejad E, et al. Among authors: teunisse afas.
J Immunother Cancer. 2020 Sep;8(2):e001326. doi: 10.1136/jitc-2020-001326.
J Immunother Cancer. 2020.
PMID: 32873723
Free PMC article.